Email
Print
Tumor Ablation Market Overview
Tumor Ablation Market size in 2020 was valued at $513.3 billion and is projected to grow with a CAGR of 12.0% during the forecast period 2021-2026. Tumor Ablation is a minimally invasive surgical method commonly used in the treatment of solid cancers. Tumor ablation is undoubtedly the most exciting and high profile procedure currently in Interventional radiology. It is considered a first-line treatment for patients with small hepatocellular carcinomas or benign tumors in the liver. The technique uses elevated temperature to eradicate alleviate blockages or tumors. This therapy can be performed using various techniques such as microwave ablation, radiofrequency ablation, Image Guided Therapy, cryoablation, and other techniques. Among these microwaves, radiofrequency, high-intensity focused ultrasound (HIFU) systems, or laser is used to heat tissue to at least 60°C for maximum efficacy. Increasing prevalence of cancer in worldwide coupled with rising aging population are the major factors driving the growth of the market. Moreover, growing technological advancement in ablation devices coupled with growing demand of minimally invasive surgeries further enhance the overall market demand for Tumor Ablation during the aforesaid period.
Tumor Ablation Market Report Coverage
The
report: “Tumor Ablation Market –
Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the
following segments of the Tumor
Ablation Market:
By
Technology: Radiofrequency (Rf) Ablation, Microwave Ablation, Cryoablation, High
Intensity Focused Ultrasound (HIFU), Image Guided Therapy, others
By Mode of Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation
By Application: Liver cancer, Lung cancer, Kidney cancer, Bone cancer, others
By Geography: North America (U.S., Canada,
Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia and Others), Asia
Pacific (China, Japan, India, South Korea, Australia & New Zealand and
Others), South America(Brazil, Argentina and others), and Rest of the World
(Middle East and Africa)
Key Takeaway
- In 2020, North America dominated the Tumor Ablation Market owing to rising incidence of cancer.
- Increasing various initiatives taken by the government organizations across the globe is also driving the market growth of Tumor Ablation.
- Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Tumor Ablation Market report.
- High cost of ablation techniques and uncertainties surrounding reimbursement are challenging the growth of the market.
Tumor Ablation Market Segment Analysis - By Technology
Based on
the Technology, Tumor Ablation Market is segmented into Radiofrequency (Rf)
Ablation, Microwave Ablation, Cryoablation, High Intensity Focused Ultrasound
(HIFU), Image Guided Therapy, others. The
Radiofrequency (Rf) Ablation segment is estimated to dominate the market during
the period 2021-2026 and is widely used method of
tumor ablation and is also a minimally invasive, repeatable procedure with a
low complication rate. The High Intensity Focused Ultrasound (HIFU), segment is
forecast to be the fastest-growing segment and is projected to grow at a CAGR
of 6.5% during the period 2021-2026. This is mainly owing to it is most
effective non-invasive therapy that uses focused ultrasound waves to thermally
ablate a portion of tissue.
Tumor Ablation Market Segment Analysis - By Mode of Treatment
Based on the Vertebral Position, Tumor Ablation Market is segmented into Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation. In 2020, Surgical Ablation is estimated to hold major share in the market. This is mainly owing to the most effective and well-established treatment option for patients. Moreover, it is a minimally invasive surgical procedure, and it does not involve surgical removal of affected tissues or tumors are also contributing to the dominance of this segment. Also, Laparoscopic Ablation is projected to grow with a CAGR of 7.1% over the period 2021-2026. This is owing to it is more accurate and accessible procedure.
Tumor Ablation Market Segment Analysis - By Geography
North
America dominated the Tumor Ablation market
share accounting for 41% of the market in 2020. This is mainly due to the presence
of key players in U.S. which focus on the development of products with
innovative features and greater effectiveness has increased in recent times
coupled with rising number of cancer patient in this region. According to,
National Cancer Institute, in 2019, there were an estimated 16.9 million cancer
survivors in the United States. The number of cancer survivors is projected to
increase to 22.2 million by 2030.
However,
the Asia-Pacific region is projected to be the fastest-growing over the period 2021-2026.
This is owing to improving healthcare infrastructure coupled with rising
advancement in ablation surgery.
Tumor Ablation Market Drivers
Increasing Prevalence of Cancer
Increasing prevalence of cancer across the globe is driving the growth of Tumor Ablation market. According to, World Health Organization (WHO), cancer is the leading cause of death globally and in 2018, around 9.6 million people died owing to cancer in worldwide. Globally, about 1 in 6 deaths is owing to cancer. Moreover, rising number of aging populations is also set to increase the market growth.
Rising Technological Advancement
Increase
in research and development of advanced technology for ablation is also driving
the market. The advanced technologies such as various imaging-guidance tools
that incorporate imaging-fusion between real-time US and CT/MRI, and high-intensity
focused ultrasound ablation. Also, the increasing adoption of minimally invasive technology
for ablation is also set to the growth of Tumor Ablation Market.
Tumor Ablation Market Challenges
High capital expenditure required for ablation
techniques and strict regulatory by government for launch of ablation devices is
challenging the market. Along with this, the uncertainties of reimbursement are also
further challenging the growth of the market.
Covid-19 Impact
Moreover, the
outbreak of COVID-19 around the world has impacted all industries including
healthcare industry. Covid- 19 affects the Tumor Ablation market including
drastic reduction in emergency surgical procedures and also overall admission
to the Emergency department (ED). Also owing to widespread of coronavirus it
affects workforce and staffing issues, procedural prioritisation. These affects
Tumor Ablation market by cancellation of scheduled surgery and shift of
surgeons to the other area.
Tumor Ablation Industry Outlook
Product launches,
Merger & Acquisitions, Joint Ventures and R&D activities are key
strategies adopted by players in the Tumor Ablation Market. Tumor Ablation top
10 companies are AngioDynamics Inc., Misonix Inc., NeuWave Medical, Inc., Medtronic
PLC, INTIO Inc., SonaCare Medical, LLC, BVM Medical Limited, Theraclion, Boston
Scientific Corporation and CONMED Corporation
Acquisitions/Product Launches:
- In August 2019, Boston Scientific Corporation received a medical device licence from Heath Canada for ICEfx cryoablation system. ICEfx cryoablation system provides a minimally invasive alternative procedure for patients with certain cancer.
Relevant Reports:
Report Code: HCR 0257
Report Code: HCR 84977
For more Lifesciences and Healthcare Market reports, please click here